...prostate cancer biopsy test in the U.S. to improve prognosis accuracy. Metamark, which acquired the HealthTronics...

...SVP and head of Intrexon's consumer sector, a newly created position, formerly president at the HealthTronics Inc....

...up front, plus up to another $45 million based on HealthTronics' future operating performance. The HealthTronics...
...close this quarter. In August 2013, Endo said HealthTronics was selling its anatomical pathology business, HealthTronics...
...for an undisclosed amount. In June 2013, Endo announced it would seek alternatives for the HealthTronics...

...Business: Diagnostic Hired: Cornelius Merlini as SVP and chief commercial officer, formerly general manager of HealthTronics...

...Endo said its HealthTronics Inc. subsidiary will sell its anatomical pathology business, HealthTronics Laboratory Solutions Inc., to...
...Metamark for an undisclosed amount. In June, Endo announced it would seek alternatives for the HealthTronics...
...revenues of $11 million for the six months ending June 30 (see BioCentury, June 10). HealthTronics...

...as R&D projects with near-term revenue potential. The company is seeking strategic alternatives for its HealthTronics...

...and R&D projects with near-term revenue potential. The company will seek strategic alternatives for its HealthTronics...

...operating expenses by mid-2014. The company also said it will seek strategic alternatives for its HealthTronics...

...and R&D projects with near-term revenue potential. The company will seek strategic alternatives for its HealthTronics...

...prostate cancer treatment Vantas histrelin, and urology services and technology from last year's acquisition of HealthTronics Inc....